New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1200+0.0700 (+2.30%)
At close: 04:00PM EDT
3.1592 +0.04 (+1.26%)
After hours: 06:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-59,920
-30,150
-39,754
-93,063
-51,777
Depreciation & amortisation
3
5
4
2
2
Stock-based compensation
4,432
387
3,628
7,785
730
Change in working capital
-909
5,164
699
-4,898
3,453
Accounts receivable
0
-
0
831
-831
Accounts payable
-3,392
2,655
-1,611
-19
1,183
Other working capital
-42,728
-21,660
-39,765
-37,710
-2,267
Other non-cash items
14,782
2,957
-4,077
54,284
39,610
Net cash provided by operating activities
-42,717
-21,657
-39,755
-37,703
-2,265
Cash flows from investing activities
Investments in property, plant and equipment
-11
-3
-10
-7
-2
Net cash used for investing activities
-11
-3
-10
-7
-2
Cash flows from financing activities
Debt repayment
-517
-4,035
-518
-1,276
0
Common stock issued
22,610
8,122
22,702
36,983
2,579
Other financing activities
-
-
-
11,050
-
Net cash used provided by (used for) financing activities
22,093
6,201
32,214
63,456
3,249
Net change in cash
-20,635
-15,459
-7,551
25,746
982
Cash at beginning of period
38,884
20,054
27,605
1,859
877
Cash at end of period
18,249
4,595
20,054
27,605
1,859
Free cash flow
Operating cash flow
-42,717
-21,657
-39,755
-37,703
-2,265
Capital expenditure
-11
-3
-10
-7
-2
Free cash flow
-42,728
-21,660
-39,765
-37,710
-2,267